Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDVertex Pharmaceuticals Incorporated Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 5 | $4.07 | $4.07 | $4.07 |
| Q2 2024 | 5 | -$12.15 | -$11.27 | -$11.63 |
| Q3 2024 | 8 | $4.06 | $4.10 | $4.08 |
| Q4 2024 | 18 | $3.55 | $4.90 | $4.02 |
| Q1 2025 | 5 | $3.77 | $5.14 | $4.35 |
| Q2 2025 | 4 | $4.44 | $4.79 | $4.58 |
| Q3 2025 | 4 | $4.63 | $4.99 | $4.78 |
| Q4 2025 | 4 | $4.80 | $5.17 | $4.95 |
Vertex Pharmaceuticals Incorporated Earnings Date And Information
Vertex Pharmaceuticals Incorporated last posted its earnings results on Monday, November 4th, 2024. The company reported $4.38 earnings per share for the quarter, topping analysts' consensus estimates of $4.14 by $0.24. The company had revenue of 2.77 B for the quarter and had revenue of 9.87 B for the year. Vertex Pharmaceuticals Incorporated has generated $14 earnings per share over the last year ($13.89 diluted earnings per share) and currently has a price-to-earnings ratio of -219.08. Vertex Pharmaceuticals Incorporated has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 3rd, 2025 based on prior year's report dates.
Vertex Pharmaceuticals Incorporated Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/05/2024 | Q3 2024 | $4.05 | $2.69 B | $2.77 B | ||
| 08/02/2024 | Q2 2024 | -$13.92 | $2.66 B | $2.63 B | ||
| 05/07/2024 | Q1 2024 | $4.26 | $2.69 B | |||
| 02/15/2024 | Q4 2023 | $3.76 | $2.52 B | |||
| 11/07/2023 | Q3 2023 | $4.01 | $2.50 B | $2.48 B | ||
| 08/02/2023 | Q2 2023 | $3.55 | $2.42 B | $2.49 B | ||
| 05/02/2023 | Q1 2023 | $2.72 | $2.37 B | |||
| 02/10/2023 | Q4 2022 | $3.19 | $2.30 B | |||
| 10/28/2022 | Q3 2022 | $3.63 | $2.23 B | $2.33 B | ||
| 08/05/2022 | Q2 2022 | $3.17 | $2.13 B | $2.20 B | ||
| 05/06/2022 | Q1 2022 | $2.99 | $2.10 B | |||
| 02/09/2022 | Q4 2021 | $3.02 | $2.07 B | |||
| 11/03/2021 | Q3 2021 | $3.30 | $1.86 B | $1.98 B | ||
| 07/30/2021 | Q2 2021 | $0.26 | $1.72 B | $1.79 B | ||
| 04/30/2021 | Q1 2021 | $2.52 | $1.72 B | |||
| 02/11/2021 | Q4 2020 | $2.32 | $1.63 B | |||
| 10/30/2020 | Q3 2020 | $2.56 | $1.49 B | $1.54 B | ||
| 07/31/2020 | Q2 2020 | $3.22 | $1.39 B | $1.52 B | ||
| 05/01/2020 | Q1 2020 | $2.32 | $1.52 B | |||
| 02/13/2020 | Q4 2019 | $2.26 | $1.41 B |
Vertex Pharmaceuticals Incorporated Earnings: FAQ's
When is Vertex Pharmaceuticals Incorporated's earnings date?
Vertex Pharmaceuticals Incorporated has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 3rd, 2025 based off last year's report dates.
Did Vertex Pharmaceuticals Incorporated beat their earnings estimates last
quarter?
In the previous quarter, Vertex Pharmaceuticals Incorporated (:VRTX) reported $4.38 earnings per share (EPS) to beat the analysts' consensus estimate of $4.14 by $0.24.
How can I listen to Vertex Pharmaceuticals Incorporated's earnings conference
call?
The conference call for Vertex Pharmaceuticals Incorporated's latest earnings report can be listened to online.
How can I read Vertex Pharmaceuticals Incorporated's conference call transcript?
The conference call transcript for Vertex Pharmaceuticals Incorporated's latest earnings report can be read online.
How much revenue does Vertex Pharmaceuticals Incorporated generate each year?
Vertex Pharmaceuticals Incorporated (:VRTX) has a recorded annual revenue of $9.87 B.
How much profit does Vertex Pharmaceuticals Incorporated generate each year?
Vertex Pharmaceuticals Incorporated (:VRTX) has a recorded net income of $9.87 B. Vertex Pharmaceuticals Incorporated has generated $14.05 earnings per share over the last four quarters.
What is Vertex Pharmaceuticals Incorporated's price-to-earnings ratio?
Vertex Pharmaceuticals Incorporated (:VRTX) has a price-to-earnings ratio of -219.08 and price/earnings-to-growth ratio is -103.52.